Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11104712 Methods for modulating an immune response

Patent 11104712 was granted and assigned to Cue Biopharma on August, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Cue Biopharma
Cue Biopharma
0
Date Filed
February 19, 2021
0
Date of Patent
August 31, 2021
0
Patent Applicant
Cue Biopharma
Cue Biopharma
0
Patent Application Number
20210219
0
Patent Citations Received
‌
US Patent 12006348 T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof
0
‌
US Patent 11987610 T-cell modulatory multimeric polypeptides and methods of use thereof
0
‌
US Patent 11993641 Methods for modulating an immune response
0
‌
US Patent 11505591 T-cell modulatory multimeric polypeptides and methods of use thereof
‌
US Patent 11530248 T-cell modulatory multimeric polypeptides and methods of use thereof
0
‌
US Patent 11708400 T-cell modulatory multimeric polypeptides and methods of use thereof
0
‌
US Patent 11767355 Methods for modulating an immune response
‌
US Patent 11370821 T-cell modulatory multimeric polypeptides and methods of use thereof
‌
US Patent 11377478 T-cell modulatory multimeric polypeptides and methods of use thereof
‌
US Patent 11851467 T-cell modulatory multimeric polypeptides and methods of use thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11104712
0

Find more entities like US Patent 11104712 Methods for modulating an immune response

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.